Clinical Effectiveness of Conventional Versus Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia

Study Title
Clinical Effectiveness of Conventional Versus Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia
Sponsor Name
Terumo BCT Biotechnologies
NCT Number
NCT02964325
IDE Number
BB16116
CMS Approval Date
2017-01-23
Clinical Trial Link
Category
B
Website